Kate Gurney

Summary

Affiliation: Amylin Pharmaceuticals
Country: USA

Publications

  1. pmc Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
    Leigh MacConell
    Amylin Pharmaceuticals, Inc San Diego, CA, USA
    Diabetes Metab Syndr Obes 5:29-41. 2012
  2. pmc Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years
    Kristin Taylor
    Amylin Pharmaceuticals, Inc, 9360 Towne Centre Drive, San Diego, CA 92121, USA
    BMC Endocr Disord 11:9. 2011

Collaborators

  • Leigh MacConell
  • Jenny Han
  • Kristin Taylor
  • Carl Brown
  • Richard Pencek
  • Brandon Walsh
  • Michael Trautmann

Detail Information

Publications2

  1. pmc Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
    Leigh MacConell
    Amylin Pharmaceuticals, Inc San Diego, CA, USA
    Diabetes Metab Syndr Obes 5:29-41. 2012
    ..The objective of this analysis was to evaluate the safety profile of exenatide twice daily and to compare its profile with that of a pooled comparator (placebo and insulin) in patients with type 2 diabetes...
  2. pmc Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years
    Kristin Taylor
    Amylin Pharmaceuticals, Inc, 9360 Towne Centre Drive, San Diego, CA 92121, USA
    BMC Endocr Disord 11:9. 2011
    ..abstract:..